| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
36,046 |
30,573 |
$5.81M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
32,317 |
28,546 |
$5.75M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
18,353 |
15,390 |
$2.70M |
| 71045 |
Radiologic examination, chest; single view |
15,350 |
12,594 |
$1.98M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
21,930 |
17,830 |
$1.44M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
9,395 |
8,544 |
$1.14M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
14,870 |
2,687 |
$1.08M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
511 |
400 |
$1.07M |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
11,802 |
10,173 |
$812K |
| 71046 |
Radiologic examination, chest; 2 views |
5,876 |
5,041 |
$787K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
691 |
513 |
$682K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
7,552 |
4,203 |
$633K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,215 |
2,932 |
$519K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,711 |
562 |
$514K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,306 |
1,915 |
$497K |
| 80050 |
General health panel |
2,889 |
2,662 |
$436K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,319 |
2,782 |
$384K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,549 |
1,003 |
$350K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
2,039 |
1,743 |
$313K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,863 |
4,416 |
$309K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
716 |
602 |
$269K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
58,449 |
42,572 |
$237K |
| 80053 |
Comprehensive metabolic panel |
41,263 |
30,230 |
$233K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
14,267 |
9,323 |
$231K |
| 87631 |
|
2,947 |
2,730 |
$223K |
| 36415 |
Collection of venous blood by venipuncture |
104,616 |
70,968 |
$205K |
| 90899 |
|
1,622 |
243 |
$198K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
15,194 |
12,564 |
$187K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
5,405 |
4,855 |
$157K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
5,386 |
4,841 |
$156K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
886 |
813 |
$156K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
10,042 |
1,935 |
$128K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,460 |
2,707 |
$124K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,659 |
1,527 |
$121K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
6,966 |
6,258 |
$120K |
| 80061 |
Lipid panel |
14,293 |
12,830 |
$117K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
4,262 |
3,909 |
$111K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
25,207 |
17,427 |
$107K |
| 81025 |
|
19,332 |
16,663 |
$105K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
485 |
329 |
$102K |
| 84484 |
|
10,176 |
7,792 |
$89K |
| 92557 |
|
801 |
669 |
$88K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,498 |
1,132 |
$82K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
82 |
42 |
$75K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
258 |
210 |
$69K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
307 |
281 |
$67K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
29 |
24 |
$64K |
| 84443 |
Thyroid stimulating hormone (TSH) |
7,128 |
6,328 |
$63K |
| 81001 |
|
29,924 |
25,123 |
$58K |
| 85027 |
|
14,323 |
10,068 |
$53K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
9,160 |
7,997 |
$53K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
48 |
38 |
$49K |
| 99220 |
|
300 |
79 |
$46K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
311 |
305 |
$43K |
| 83735 |
|
12,213 |
6,952 |
$39K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
9,541 |
6,842 |
$37K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,456 |
1,311 |
$37K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
6,756 |
1,404 |
$36K |
| 83690 |
|
10,221 |
8,360 |
$35K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
380 |
101 |
$33K |
| 95811 |
|
21 |
14 |
$32K |
| 92567 |
|
1,318 |
1,125 |
$29K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,835 |
3,960 |
$26K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,803 |
995 |
$25K |
| 80076 |
|
5,476 |
4,693 |
$24K |
| 88142 |
|
2,207 |
1,980 |
$24K |
| 76818 |
|
253 |
115 |
$22K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,048 |
976 |
$22K |
| 73560 |
|
637 |
455 |
$20K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
849 |
501 |
$20K |
| 96523 |
|
386 |
252 |
$17K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
807 |
771 |
$17K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
836 |
451 |
$17K |
| 83880 |
|
856 |
677 |
$14K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
87 |
61 |
$14K |
| 73564 |
|
255 |
177 |
$14K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
1,238 |
218 |
$14K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,747 |
1,406 |
$13K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
76 |
72 |
$13K |
| 86780 |
|
989 |
927 |
$12K |
| 83970 |
|
684 |
574 |
$12K |
| 83655 |
|
949 |
884 |
$12K |
| 97010 |
|
650 |
114 |
$11K |
| 82728 |
|
1,457 |
1,146 |
$11K |
| 82607 |
|
983 |
914 |
$11K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
920 |
506 |
$10K |
| 84439 |
|
1,195 |
1,100 |
$10K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,549 |
427 |
$10K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
63 |
54 |
$9K |
| 82043 |
|
2,343 |
2,134 |
$9K |
| 97161 |
|
150 |
103 |
$8K |
| 80074 |
|
167 |
161 |
$7K |
| 96376 |
|
2,323 |
774 |
$7K |
| 87150 |
|
228 |
213 |
$7K |
| 83550 |
|
1,445 |
1,129 |
$7K |
| 73630 |
|
172 |
124 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
669 |
453 |
$7K |
| 85610 |
|
3,518 |
2,572 |
$7K |
| 85730 |
|
2,242 |
1,774 |
$6K |
| 83540 |
|
1,507 |
1,187 |
$5K |
| 82570 |
|
1,376 |
1,284 |
$5K |
| 86850 |
|
834 |
758 |
$5K |
| 86762 |
|
360 |
334 |
$5K |
| 87340 |
|
565 |
531 |
$4K |
| 96417 |
|
52 |
24 |
$3K |
| 70486 |
|
14 |
12 |
$3K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
61 |
60 |
$3K |
| 84702 |
|
374 |
316 |
$3K |
| 93017 |
|
32 |
26 |
$3K |
| 87807 |
|
211 |
90 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
24 |
12 |
$3K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
120 |
42 |
$2K |
| 82077 |
|
213 |
166 |
$2K |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
261 |
98 |
$2K |
| 84100 |
|
945 |
815 |
$2K |
| 86901 |
|
807 |
735 |
$2K |
| 86900 |
|
780 |
708 |
$2K |
| 86140 |
|
721 |
648 |
$2K |
| 82947 |
|
626 |
503 |
$2K |
| 97162 |
|
16 |
13 |
$2K |
| 97535 |
Self-care/home management training, each 15 minutes |
30 |
13 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
38 |
26 |
$1K |
| 73030 |
|
34 |
29 |
$1K |
| 85652 |
|
735 |
663 |
$1K |
| 96367 |
|
61 |
24 |
$1K |
| 73502 |
|
17 |
17 |
$937.33 |
| 74022 |
|
13 |
12 |
$914.60 |
| 87040 |
|
72 |
52 |
$854.50 |
| 87808 |
|
90 |
79 |
$769.62 |
| 80069 |
|
173 |
150 |
$761.86 |
| 83605 |
|
96 |
85 |
$739.10 |
| 70360 |
|
12 |
12 |
$680.04 |
| 85379 |
|
119 |
93 |
$665.46 |
| 72100 |
|
28 |
25 |
$656.02 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
58 |
54 |
$615.76 |
| 97116 |
|
81 |
36 |
$559.38 |
| 84145 |
|
30 |
25 |
$540.32 |
| 87081 |
|
86 |
80 |
$503.92 |
| 84550 |
|
155 |
141 |
$441.82 |
| 92588 |
|
12 |
12 |
$372.92 |
| 87210 |
|
134 |
120 |
$323.31 |
| 84153 |
|
26 |
24 |
$284.65 |
| 82950 |
|
62 |
56 |
$283.83 |
| J1453 |
Injection, fosaprepitant, 1 mg |
40 |
12 |
$277.50 |
| 82962 |
|
226 |
159 |
$250.48 |
| 84156 |
|
90 |
84 |
$228.27 |
| 83615 |
|
77 |
52 |
$205.85 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
13 |
$198.45 |
| 82565 |
|
111 |
101 |
$188.95 |
| 82105 |
|
12 |
12 |
$186.46 |
| 85018 |
|
210 |
164 |
$174.89 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
3,096 |
1,089 |
$170.50 |
| J2704 |
Injection, propofol, 10 mg |
1,289 |
962 |
$88.58 |
| 84207 |
|
15 |
12 |
$70.74 |
| 82550 |
|
16 |
16 |
$70.20 |
| 87077 |
|
27 |
13 |
$58.98 |
| 82746 |
|
17 |
13 |
$56.43 |
| 87186 |
|
26 |
12 |
$54.50 |
| 86592 |
|
41 |
37 |
$51.63 |
| G0378 |
Hospital observation service, per hour |
85 |
25 |
$17.14 |
| 85014 |
|
142 |
96 |
$13.73 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,575 |
5,442 |
$6.07 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,323 |
3,872 |
$4.82 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,301 |
897 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
956 |
508 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
81 |
64 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
49 |
26 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
272 |
243 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
13 |
12 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
14 |
12 |
$0.00 |
| 77003 |
|
15 |
14 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
170 |
98 |
$0.00 |
| C1760 |
Closure device, vascular (implantable/insertable) |
54 |
24 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
26 |
25 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
16 |
15 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
480 |
260 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
663 |
532 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
279 |
195 |
$0.00 |
| C1769 |
Guide wire |
56 |
37 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
412 |
328 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
34 |
34 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
403 |
177 |
$0.00 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
40 |
27 |
$0.00 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
71 |
54 |
$0.00 |
| 36591 |
|
22 |
12 |
$0.00 |
| 84703 |
|
44 |
24 |
$0.00 |